![]() |
Moderna Vaccine has new Neutralizing Activity
Against the South African and Brazilian Varients. UK is due 17million Moderna Vaccines in the Spring. SkyNewsHD Live |
a parody was made based on Alphabeat - Fascination, titled ''Vaccination'' by a Doctor David more like a fun way to make people aware they need to vaccinate 'our way out of this pandemic mess' |
Quote:
|
Quote:
Thank the lawd ... Sent from my iPhone using Tapatalk Pro |
Moderna vaccine appears to work against variants
https://www.bbc.co.uk/news/health-55797312 That link says UK and South Africa. |
We're doing so well with the vaccines.
I'm so proud! |
Quote:
https://pbs.twimg.com/media/EsnCxCZV...jpg&name=small |
|
God I really, really, really hope all of these different jabs work against every variant.
|
|
Quote:
This sounds ominous.. Sent from my iPhone using Tapatalk Pro |
Infact, its to do with UK Astra Vaccine
reducing the amount of stock going to them. Vaccine Shortages. Ref:GMBHD itv. |
Quote:
|
Quote:
This down to the UK telling the EU they will get 80Million doses from UK AstraZeneca by March 2021. Now they have been told they will get 30 million. Brussels Reporter on BBCnewsHD Live |
Quote:
|
Quote:
Its down to Johnson PM wanting more UK stock we are up to Over 6 Million vaccinated. The EU Legally Ordered AstraZenneca From Oxford for many of its nations. [But "some" EU nations have yet to approve it] |
https://www.bbc.com/news/world-europe-55805903
EU to tighten vaccine exports with Astra-Zeneca Other nations, including Australia and Thailand, have said they have also been told of a drop in AstraZeneca supply. |
Quote:
Yes they can not Supply the World Fully until the UK is all done. |
Quote:
then we have to up the production of Pfizer instead, or speed up the Janssen's progress to compensate |
|
Imperial pause trials on their vaccine to concentrate on tackling the variants
https://www.msn.com/en-gb/health/med...ts/ar-BB1d6LFa cientists at Imperial College London have announced they will not be proceeding with large-scale testing of their Covid-19 vaccine because of the rapid approval of other jabs within the UK. Professor Robin Shattock said his team would instead be using the RNA technology behind the vaccine to target new and emerging coronavirus variants that have been identified around the world. “Although our first generation Covid-19 vaccine candidate is showing promise in early clinical development, the broader situation has changed with the rapid rollout of approved vaccines,” Prof Shattock said in a statement on Tuesday. “It is not the right time to start a new efficacy trial for a further vaccine in the UK, with the emphasis rightly placed on mass vaccination in response to the rapid spread of the new variant.” He said his team would begin working to develop the vaccine technology as “a safety net to catch escape mutations, reach variants that other vaccines may not, and meet potential needs for annual booster vaccinations”. Similar in design to the Moderna and Pfizer/BioNTech vaccines, the Imperial College jab makes use of self-amplifying RNA to deliver genetic instructions to human muscle cells, which then go on to produce the spike protein found on the surface of Sars-CoV-2. |
|
Quote:
That sounds ominous ... Sent from my iPhone using Tapatalk Pro |
Quote:
|
Quote:
|
All times are GMT. The time now is 07:00 AM. |
Powered by vBulletin® Version 3.8.11
Copyright ©2000 - 2025, vBulletin Solutions Inc.
User Alert System provided by
Advanced User Tagging (Pro) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.